Product
Conventional Treatment
1 clinical trial
1 indication
Indication
Nonalcoholic Fatty Liver DiseaseClinical trial
Evaluation of Potential Benefits of Trimetazidine in the Management of Pateints With Metabolic Associated Fatty Liver Disease ( MAFLD)Status: Recruiting, Estimated PCD: 2024-06-01